Background Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use ...

Background Smoking is a significant risk factor for neurological disorders, yet its global impact on these conditions remains underexplored. Methods Using Global Burden of Diseases 2021 data, we ...

Background A few case reports have shown controversial results of rituximab efficacy in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Objective To analyse the ...

Tremor is one of the clinical manifestations of dystonia; however, there are no specific therapeutic trials evaluating the efficacy of treatments for dystonic tremor (DT), tremor associated with ...

Objective No definitive comparative studies of the efficacy of ‘awake’ deep brain stimulation (DBS) for Parkinson’s disease (PD) under local or general anaesthesia exist, and there remains significant ...

Neuroimage Nord, Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Correspondence to: G Thomalla Klinik und Poliklinik für Neurologie, Universitätsklinikum ...

Background Cerebellar ataxias are the result of diverse disease processes that can be genetic or acquired. Establishing a diagnosis requires a methodical approach with expert clinical evaluation and ...

Background Staging of disease severity is useful for prognosis, decision-making and resource planning. However, no commonly used, validated staging system exists for amyotrophic lateral sclerosis (ALS ...

4 Institute of Cardiovascular and Cell Sciences, St Georges University of London, London, UK 5 School of Health Professions, Peninsula Allied Health Centre, University of Plymouth, Plymouth, UK ...

1 School of Health Professions and Rehabilitation Sciences, University of Southampton, Southampton General Hospital, Southampton, UK 2 Faculty of Health and Social Care, London South Bank University, ...

OBJECTIVES The detection of the protein 14–3–3 in the CSF has been shown to be a reliable and sensitive marker for sporadic Creutzfeldt-Jakob disease (CJD). Other brain-specific proteins such as ...

Correspondence to Dr William Stewart, Department of Neuropathology, NHS Greater Glasgow and Clyde, Glasgow G51 4TF, UK; william.stewart{at}glasgow.ac.uk Introduction There is growing recognition of an ...